UL 250 Pill: pink, oval, 14mm
The pill with imprint UL 250 (Pink, Oval, 14mm) has been identified as Divalproex Sodium Delayed Release 250 mg and is used for Bipolar Disorder, Mania, Migraine Prevention, Seizures, and Epilepsy. It belongs to the drug class fatty acid derivative anticonvulsants and is not a controlled substance.
Images for UL 250
Divalproex Sodium Delayed Release
- Imprint
- UL 250
- Strength
- 250 mg
- Color
- Pink
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Unichem Pharmaceuticals (USA), Inc.
- National Drug Code (NDC)
- 29300-0139
- Inactive Ingredients
-
alcohol,
butyl alcohol,
microcrystalline cellulose,
D&C Red No. 30,
FD&C Blue No. 2,
ferric oxide red,
ferrosoferric oxide,
hypromellose 2910 (6 mPa.s),
isopropyl alcohol,
lactose monohydrate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
polyethylene glycol 3000,
propylene glycol,
shellac,
silicon dioxide,
sodium bicarbonate,
sodium lauryl sulfate,
corn starch,
magnesium silicate,
titanium dioxide,
triacetin,
triethyl citrate,
vanillin
Note: Inactive ingredients may vary.
Related images for "UL 250"
More about divalproex sodium
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (514)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: fatty acid derivative anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Professional resources
- Divalproex Capsules prescribing information
- Divalproex Delayed Release (FDA)
- Divalproex Delayed Release Tablets (FDA)
- Divalproex Extended Release (FDA)
- Divalproex Sprinkle (FDA)
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.